PMS-CONJUGATED ESTROGENS C.S.D. TABLET

Šalis: Kanada

kalba: anglų

Šaltinis: Health Canada

Veiklioji medžiaga:

CONJUGATED ESTROGENS

Prieinama:

PHARMASCIENCE INC

ATC kodas:

G03CA57

INN (Tarptautinis Pavadinimas):

CONJUGATED ESTROGENS

Dozė:

0.3MG

Vaisto forma:

TABLET

Sudėtis:

CONJUGATED ESTROGENS 0.3MG

Vartojimo būdas:

ORAL

Vienetai pakuotėje:

100

Recepto tipas:

Prescription

Gydymo sritis:

ESTROGENS

Produkto santrauka:

Active ingredient group (AIG) number: 0106442002; AHFS:

Autorizacija statusas:

CANCELLED POST MARKET

Leidimo data:

2017-09-30

Prekės savybės

_pms-Conjugated Estrogens CSD (tablets) _
_ _
_ _
_ _
_ page 1 of 42 _
_ _
PRODUCT MONOGRAPH
PR
PMS-CONJUGATED ESTROGENS CSD
(conjugated estrogens tablets, CSD)
0.3 mg, 0.625 mg, 0.9 mg, and 1.25 mg
ESTROGENIC HORMONES
PHARMASCIENCE INC.
DATE OF REVISION:
6111 Royalmount Avenue, Suite 100
AUGUST 28, 2009
Montreal, Quebec
H4P 2T4
CONTROL NUMBER: 120633
_pms-Conjugated Estrogens CSD (tablets) _
_ _
_ _
_ _
_ page 2 of 42 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL
INFORMATION……………………………...
3
SUMMARY PRODUCT
INFORMATION……………………………………….3
INDICATIONS AND CLINICAL
USE…………………………………………...3
CONTRAINDICATIONS…………………………………………………………4
WARNINGS AND
PRECAUTIONS…………………………………….……….5
ADVERSE
REACTIONS………………………………………………………...13
DRUG
INTERACTIONS………………………………………………………...18
DOSAGE AND
ADMINISTRATION…………………………………………...20
OVERDOSAGE………………………………………………………………….22
ACTION AND CLINICAL
PHARMACOLOGY……………………………….23
STORAGE AND
STABILITY…………………………………………………...26
SPECIAL HANDLING
INSTRUCTIONS………………………………………26
DOSAGE FORMS, COMPOSITION AND PACKAGING……………………..26
PART II: SCIENTIFIC
INFORMATION…………………………………………….
27
PHARMACEUTICAL
INFORMATION………………………………………...27
CLINICAL
TRIALS……………………………………………………………...27
DETAILED
PHARMACOLOGY………………………………………………..32
REFERENCES…………………………………………………………………...33
PART III: CONSUMER
INFORMATION……………………………………………………
37
_pms-Conjugated Estrogens CSD (tablets) _
_ _
_